75,411 resources
By Version
By Authority
By Realm
Start Prev Rows 63000 - 63200 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth |
---|---|---|---|---|---|---|---|---|---|
ca.on.ehr.r4 | R4 | ValueSet/ValueSet-ReportableTestIndicator | Reportable Test Indicator EHR | active | 2025-04 | ca | national | ||
ca.on.oh-olis | R4 | ValueSet/olis-ReportableTestIndicator | ReportableTestIndicator | active | hl7 | ||||
hl7.fhir.us.core | R4 | ValueSet/us-core-laboratory-test-codes | US Core Laboratory Test Codes | trial-use | 3 | cgp | 2022-11 | us | hl7 |
fhir.cdc.opioid-cds-r4 | R4 | ValueSet/observation-category-laboratory | Observation Category Laboratory | active | 2023-05 | us | hl7 | ||
myhealth.eu.fhir.laboratory | R4 | ValueSet/eHDSIPerformerFunction | eHDSI Performer Function | trial-use | 2 | 2025-03 | eu | ||
hl7.fhir.uv.lab-report | R4 | ValueSet/reportBundleType-uv-lab | Laboratory Report Bundle Types | trial-use | 2 | oo | 2025-01 | uv | hl7 |
hl7.fhir.uv.lab-report | R4 | ValueSet/reportType-uv-lab | Laboratory Report Types | trial-use | 2 | oo | 2025-01 | uv | hl7 |
hl7.fhir.eu.laboratory | R4 | ValueSet/lab-reportType-eu-lab | Laboratory Report Types | trial-use | 2 | 2025-07 | eu | hl7 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.1002 | Lab Test Result Name | active | 2020-01 | us | |||
ch.fhir.ig.ch-vacd | R4 | ValueSet/ch-vacd-laboratory-serology-vs | Laboratory Serology for Immunization | active | 2025-05 | ch | hl7 | ||
hl7.fhir.uv.lab-report | R4 | ValueSet/specialty-uv-lab | Laboratory Specialty | trial-use | 2 | oo | 2025-01 | uv | hl7 |
hl7.fhir.eu.laboratory | R4 | ValueSet/lab-specialty-eu-lab | Laboratory Specialty | trial-use | 2 | 2025-07 | eu | hl7 | |
hl7.fhir.uv.lab-report | R4 | ValueSet/specimenType-uv-lab | Specimen Types | trial-use | 2 | oo | 2025-01 | uv | hl7 |
hl7.fhir.eu.laboratory | R4 | ValueSet/lab-specimenType-eu-lab | Specimen Types | trial-use | 2 | 2025-07 | eu | hl7 | |
hl7.fhir.uv.lab-report | R4 | ValueSet/studyType-uv-lab | Laboratory Study Types | trial-use | 2 | oo | 2025-01 | uv | hl7 |
hl7.fhir.eu.laboratory | R4 | ValueSet/lab-studyType-eu-lab | Laboratory Study Types | trial-use | 2 | 2025-07 | eu | hl7 | |
hl7.fhir.uv.lab-report | R4 | ValueSet/obsCode-loinc-uv-lab | Laboratory Code: LOINC | trial-use | 2 | oo | 2025-01 | uv | hl7 |
hl7.fhir.eu.laboratory | R4 | ValueSet/lab-obsCode-loinc-eu-lab | Laboratory Code: LOINC | trial-use | 2 | 2025-07 | eu | hl7 | |
hl7.fhir.uv.lab-report | R4 | ValueSet/obsCode-npu-uv-lab | Laboratory Code: NPU | trial-use | 2 | oo | 2025-01 | uv | hl7 |
hl7.fhir.eu.laboratory | R4 | ValueSet/lab-obsCode-npu-eu-lab | Laboratory Code: NPU | trial-use | 2 | 2025-07 | eu | hl7 | |
hl7.fhir.uv.lab-report | R4 | ValueSet/obsCode-uv-lab | Laboratory Code | trial-use | 2 | oo | 2025-01 | uv | hl7 |
hl7.fhir.eu.laboratory | R4 | ValueSet/lab-obsCode-eu-lab | Laboratory Code | trial-use | 2 | 2025-07 | eu | hl7 | |
hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-HER2byFISHVSInterpretationTestsVS | BC HER2byFISHVSInterpretationTestsVS ValueSet | draft | 2018-08 | us | hl7 | ||
hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-EstrogenReceptorInterpretationTestsVS | BC EstrogenReceptorInterpretationTestsVS ValueSet | draft | 2018-08 | us | hl7 | ||
hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-HER2byIHCInterpretationTestsVS | BC HER2byIHCInterpretationTestsVS ValueSet | draft | 2018-08 | us | hl7 | ||
hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-ProgesteroneReceptorInterpretationTestsVS | BC ProgesteroneReceptorInterpretationTestsVS ValueSet | draft | 2018-08 | us | hl7 | ||
hl7.fhir.uv.lab-report | R4 | ValueSet/technique-uv-lab | Laboratory Techniques | trial-use | 2 | oo | 2025-01 | uv | hl7 |
hl7.fhir.cz.lab | R4 | ValueSet/cz-lab-technique-vs | Laboratory Techniques | trial-use | 2 | 2025-07 | cz | hl7 | |
hl7.fhir.eu.laboratory | R4 | ValueSet/lab-technique-eu-lab | Laboratory Techniques | trial-use | 2 | 2025-07 | eu | hl7 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.1003 | Observation Method | active | 2008-01 | us | |||
hl7.eu.fhir.idea4rc | R4 | ValueSet/pos-neg-nt-athena-eu-i4rc | Positive-Negative-No Test: Athena | active | 2025-07 | eu | hl7 | ||
hl7.eu.fhir.idea4rc | R4 | ValueSet/yes-no-unk-athena-eu-i4rc | Yes-No-Unk: Athena | active | 2025-07 | eu | hl7 | ||
de.gecco | R4 | ValueSet/gecco-valueset-laboratory-tests | Laboratory Tests GECCO | active | |||||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.8037 | Test Type (Brucellosis) | active | 2021-01 | us | |||
de.medizininformatikinitiative.kerndatensatz.laborbefund | R4 | ValueSet/mii-vs-labor-laborbereich | MII VS Labor Laborbereich | active | 2023-12 | de | |||
hl7.terminology | R5 | ValueSet/v3-LacrimalPunctaRoute | LacrimalPunctaRoute | active | 2014-03 | uv | hl7 | ||
smart.who.int.ips-pilgrimage | R4 | ValueSet/Language | Language | draft | 2025-05 | who | |||
nictiz.fhir.nl.stu3.geboortezorg | R3 | ValueSet/2.16.840.1.113883.2.4.11.141--20130320000000 | Language Ability Proficiency | active | nl | ||||
synapxe.rcm.snapshots | R5 | ValueSet/rcm-language | RCM Language | active | 2024-08 | ||||
healthdata.be.r4.cbb | R4 | ValueSet/LanguageControlListening | LanguageControlListening | draft | |||||
healthdata.be.r4.cbb | R4 | ValueSet/LanguageControlReading | LanguageControlReading | draft | |||||
healthdata.be.r4.cbb | R4 | ValueSet/LanguageControlSpeaking | LanguageControlSpeaking | draft | |||||
laniado.test.fhir.r4 | R4 | ValueSet/k-safa | k-safa | draft | |||||
ca.on.oh.mha-pds | R4 | ValueSet/Language | Language | active | 2022-08 | ca | hl7 | ||
ca.infoway.io.erec | R4 | ValueSet/human-language | Human Language | draft | national | ||||
ca.infoway.io.erec | R4 | ValueSet/preference-type | Preference Type Code | draft | national | ||||
PCR.R4.1-1-0-pkg | R4 | ValueSet/Language | Language | active | |||||
hl7.eu.fhir.unicom | R5 | ValueSet/language-ema-vs | EMA SPOR Language | draft | 2025-06 | eu | hl7 | ||
ans.fr.nos | R4 | ValueSet/JDV-J115-Langue-ENREG | JDV_J115-Langue-ENREG | active | 2024-09 | fr | national | ||
ans.fr.nos | R4 | ValueSet/JDV-J82-Langue-RASS | JDV_J82-Langue-RASS | active | 2024-09 | fr | national | ||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3097 | Present Absent Unknown Not Examined | active | 2008-01 | us | |||
hl7.terminology | R5 | ValueSet/v3-LaryngealRoute | LaryngealRoute | active | 2014-03 | uv | hl7 | ||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7612 | Late Clinical Manifestation (STD) | active | 2021-01 | us | |||
cce.fhir.minimal | R4 | ValueSet/ValueSet-cce-core-ValueSet-TumorSiteLocationVS | Tumor Site Location VS | draft | |||||
cce.fhir | R4 | ValueSet/ValueSet-cce-core-ValueSet-SitelocationVS | SitelocationVS | draft | |||||
nictiz.fhir.nl.stu3.geboortezorg | R3 | ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.20.7.2--20200901000000 | LateraliteitCodelijst | active | nl | ||||
nictiz.fhir.nl.r4.zib2020 | R4 | ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.20.2--20200901000000 | LateraliteitCodelijst | active | nl | hl7 | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.1.12--20171231000000 | LateraliteitCodelijst | active | nl | hl7 | |||
hl7.fhir.be.core-clinical | R4 | ValueSet/be-vs-laterality | Laterality | active | 1 | 2021-01 | be | hl7 | |
ehealthplatform.be.r4.federalprofiles | R4 | ValueSet/be-vs-laterality | Laterality | active | 2021-01 | hl7 | |||
hl7.cda.uv.ips | R4 | ValueSet/2.16.840.1.113883.11.22.57--20171212192725 | Laterality (qualifier) | draft | 2024-08 | uv | hl7 | ||
healthdata.be.r4.cbb | R4 | ValueSet/Laterality | Laterality | draft | |||||
silfhirprofileig | R5 | ValueSet/sghi-laterality | Laterality Value Sets | active | 2025-07 | ||||
ch.fhir.ig.ch-crl | R4 | ValueSet/nkrs-icdo3laterality | NKRS - ICD-O-3 Laterality | active | 2022-02 | ch | hl7 | ||
nr.gp.leumit | R4 | ValueSet/vs-body-site-laterality | Body Site Laterality | draft | 2025-03 | il | |||
hl7.terminology | R5 | ValueSet/v3-LavageRoute | LavageRoute | active | 2014-03 | uv | hl7 | ||
dk.kip.rkkp.fhir.ig.core | R4 | ValueSet/LedbaandsrekonstruktionDKRR | Ledbåndsrekonstruktioner (DKRR) | active | 2022-09 | ||||
ca.on.oh.corhealth | R4 | ValueSet/CorHealth52LeftVentricularEjectionFractionGradeVS | Left Ventricular Ejection Fraction Grade | active | |||||
dk.kip.rkkp.fhir.ig.core | R4 | ValueSet/LeftRight | Left or right | active | 2022-07 | ||||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.883 | PHIN Questions | active | 2013-01 | us | |||
hl7.org.nz.fhir.ig.formulary | R4B | ValueSet/medicine-classification-code | Legal Medication status | active | 2025-08 | nz | hl7 | ||
tewhatuora.hip-core | R4 | ValueSet/hpi-legal-entity-type-1.0 | Legal Entity Type | retired | 2020-02 | national | |||
signal.core.r4 | R4 | ValueSet/questionnaire-ccars-legal-status | Questionnaire CCARS Legal Status | draft | 1 | pa | us | hl7 | |
healthdata.be.r4.cbb | R4 | ValueSet/LegalStatus | LegalStatus | draft | |||||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7714 | Legionella Diagnosis (RIBD) | active | 2018-01 | us | |||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7715 | Legionella Exposure (RIBD) | active | 2018-01 | us | |||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7737 | Legionellosis Serogroup (RIBD) | active | 2018-01 | us | |||
kbv.ita.aws | R4 | ValueSet/KBV_VS_AW_Leistungsart | KBV_VS_AW_Leistungsart | active | 2018-10 | ||||
de.gkvsv.erezeptabrechnungsdaten | R4 | ValueSet/GKVSV-VS-ERP-Leistungserbringer-Sitz | GKVSV_VS_ERP_Leistungserbringer_Sitz | active | 2024-02 | ||||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7770 | Length of Time Drug Taken (TB) | active | 2018-01 | us | |||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7468 | Length of Gestation in Weeks | active | 2016-01 | us | |||
ans.fhir.fr.eclaire | R4 | ValueSet/eclaire-status-recruitment-vs | Statut de recrutement Value Set | draft | 2024-02 | fr | national | ||
ans.fr.nos | R4 | ValueSet/JDV-J264-ModeEtCentreDePriseEnCharge-MDPH | JDV_J264-ModeEtCentreDePriseEnCharge-MDPH | active | 2024-06 | fr | national | ||
ca.on.oh.corhealth | R4 | ValueSet/CorHealth127LesionLocationVS | Lesion Location | active | |||||
hl7.fhir.us.registry-protocols | R4 | ValueSet/LesionSegmentNumber | Lesion Segment Number | active | cic | 2023-11 | us | hl7 | |
ca.on.oh.corhealth | R4 | ValueSet/CorHealth128LesionTypeVS | Lesion Type | active | |||||
dk.kip.rkkp.fhir.ig.core | R4 | ValueSet/PatobankSNOMEDLeukemiaDiagnose | Leukæmi diagnoser | active | 2022-06 | ||||
nr.gp.leumit | R4 | ValueSet/visit-expertise | Visit Expertise Codes | draft | il | ||||
nr.gp.leumit | R4 | ValueSet/encounter-type | Leumit encounter types | draft | il | ||||
ihe.pcc.mpsc | R4 | ValueSet/Level.Of.Responsiveness.AVPU.VS | Level Of Responsiveness AVPU Value Set | draft | 2025-03 | uv | ihe | ||
caseworks.mhaie002 | R4 | ValueSet/vs-EducationLevel | EducationLevelValueSet | active | |||||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.921 | Emergency Department Acuity | active | 2008-01 | us | |||
hl7.fhir.us.mcode | R4 | ValueSet/mcode-clark-level-value-vs | Clark Level Value Set | active | cic | 2025-02 | us | hl7 | |
nictiz.fhir.nl.stu3.geboortezorg | R3 | ValueSet/2.16.840.1.113883.2.4.3.11.60.90.77.11.207--20201112144120 | Leven voelen | active | nl | ||||
nictiz.fhir.nl.r4.zib2020 | R4 | ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.5.1--20200901000000 | LevensovertuigingCodelijst | active | nl | hl7 | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.5.1--20171231000000 | LevensovertuigingCodelijst | active | nl | hl7 | |||
smart.who.int.ips-pilgrimage | R4 | ValueSet/LicensingModel | Licensing Model | draft | 2025-05 | who | |||
nictiz.fhir.nl.r4.zib2020 | R4 | ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.12.5--20200901000000 | LichaamsbewegingCodelijst | active | nl | hl7 | |||
nictiz.fhir.nl.stu3.zib2017 | R3 | ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.12.5--20171231000000 | LichaamsbewegingCodelijst | active | nl | hl7 | |||
rapportendoscopiequebec.test | R4 | ValueSet/ca-qc-endo-valueset-lienusagerendo | LienUsagerEndo | active | 2024-05 | ||||
RapportEndoscopieQuebec.test | R4 | ValueSet/ca-qc-endo-valueset-lienUsagerEndo | LienUsagerEndo | active | 2023-09 | ||||
ans.fr.nos | R4 | ValueSet/JDV-J235-LieuFormation-EPARS | JDV_J235-LieuFormation-EPARS | active | 2024-07 | fr | national | ||
healthdata.be.r4.cbb | R4 | ValueSet/LifeStance | LifeStance | draft | |||||
signal.core.r4 | R4 | ValueSet/questionnaire-answers-status | QuestionnaireResponseStatus | draft | 3 | fhir | 2019-10 | us | hl7 |
nictiz.fhir.nl.stu3.geboortezorg | R3 | ValueSet/2.16.840.1.113883.2.4.11.188--20140102000000 | Ligging | active | nl | ||||
nictiz.fhir.nl.stu3.geboortezorg | R3 | ValueSet/2.16.840.1.113883.2.4.11.177--20131224000000 | LiggingBijGeboorte22 | active | nl | ||||
nictiz.fhir.nl.stu3.zib2017 | R3 | ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.10.2.3--20171231000000 | LijnStatusCodelijst | active | nl | hl7 | |||
hl7.fhir.us.mcode | R4 | ValueSet/mcode-tnm-distant-metastases-staging-type-max-vs | TNM Distant Metastases Staging Type Maximum Value Set | active | 4 | cic | 2025-02 | us | hl7 |
hl7.fhir.us.mcode | R4 | ValueSet/mcode-tnm-primary-tumor-staging-type-max-vs | TNM Primary Tumor Staging Type Maximum Value Set | active | 4 | cic | 2025-02 | us | hl7 |
hl7.fhir.us.mcode | R4 | ValueSet/mcode-tnm-regional-nodes-staging-type-max-vs | TNM Regional Nodes Staging Type Maximum Value Set | active | 4 | cic | 2025-02 | us | hl7 |
hl7.fhir.us.mcode | R4 | ValueSet/mcode-tnm-stage-group-staging-type-max-vs | TNM Stage Group Staging Type Maximum Value Set | active | 4 | cic | 2025-02 | us | hl7 |
hl7.fhir.us.mcode | R4 | ValueSet/mcode-condition-status-trend-max-vs | Condition Status Trend Maximum Value Set | active | 3 | cic | 2025-02 | us | hl7 |
kl.dk.fhir.children | R4 | ValueSet/ParentTypes | ForælderTyper | active | 2024-10 | dk | |||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.941 | Susceptibility Result | active | 2008-01 | us | |||
dk.kip.rkkp.fhir.ig.core | R4 | ValueSet/LimnavnDHDB | Limnavn (DHDB) | active | 2022-07 | ||||
healthdata.be.r4.cbb | R4 | ValueSet/LineStatus | LineStatus | draft | |||||
dk.kip.rkkp.fhir.ig.core | R4 | ValueSet/LinerCrosslinkedDHR | Liner - Crosslinked (DHR) | active | 2022-11 | ||||
dk.kip.rkkp.fhir.ig.core | R4 | ValueSet/LinerMedPostDKR | Liner komponent med Post (DKR) | active | 2023-12 | ||||
dk.kip.rkkp.fhir.ig.core | R4 | ValueSet/LinerUdenPostDKR | Liner komponent uden Post (DKR) | active | 2023-12 | ||||
dk.kip.rkkp.fhir.ig.core | R4 | ValueSet/LinertypeDHR | Linertype - (DHR) | active | 2022-11 | ||||
hl7.terminology | R5 | ValueSet/v3-LingualRoute | LingualRoute | active | 2014-03 | uv | hl7 | ||
hl7.terminology | R5 | ValueSet/v3-RoleClassPersonalRelationship | RoleClassPersonalRelationship | active | 2014-03 | uv | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.636 | Lp(a) Test_CPT | active | 2025-03 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.637 | LP(a) Test | active | 2025-03 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.634 | Lp(a) Test_LOINC | active | 2025-03 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.633 | Lp(a) Test_SNOMED | active | 2025-03 | us | hl7 | ||
ca.on.health.idms | R5 | ValueSet/IDMS-ValueSet-Letter-Types-ACTIVE | Letter Types (Active Only) | active | 2025-01 | ||||
ca.on.health.idms | R5 | ValueSet/VALUESET-PACKAGE-TYPE-ACTIVE | Package Types (Active Only) | active | 2025-01 | ||||
hl7.fhir.uv.radiation-dose-summary | R4 | ValueSet/isotope-rds-vs | Isotopes Value Set | trial-use | 2 | ii | 2025-05 | uv | hl7 |
ca.on.health.idms | R5 | ValueSet/IDMS-VALUESET-AUDIT-ENTITY-TYPE | Audit Entity Type | active | 2025-01 | ||||
ca.on.health.idms | R5 | ValueSet/064df573-b528-420c-8935-5b70fd731511 | Authorization Roles | active | 2025-01 | ||||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3241 | Notifiable Event Condition (Flu) | active | 2009-01 | us | |||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3594 | Campylobacter Organism | active | 2010-01 | us | |||
ca.on.health.idms | R5 | ValueSet/5bce5e52-9a9b-4483-9430-cf83f61b8929 | Child Request Types | active | 2025-01 | ||||
ca.on.health.idms | R5 | ValueSet/IDMS-VALUESET-COMMITTEE-RECOMMENDATION-NEW | Committee Recommendation - New | active | 2025-01 | ||||
ca.on.health.idms | R5 | ValueSet/IDMS-VALUESET-COMMITTEE-RECOMMENDATION | Committee Recommendation | active | 2025-01 | ||||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.988 | Countermeasure Encounter Purpose | active | 2008-01 | us | |||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.989 | Countermeasure Encounter Type | active | 2008-01 | us | |||
hl7.fhir.us.resp-net | R4 | ValueSet/resp-net-labtest-covid-codes | resp-net-labtest-covid-codes | draft | 2025-08 | us | hl7 | ||
ca.on.health.idms | R5 | ValueSet/IDMS-VALUESET-CROSS-REFERENCE-TYPE | Cross Reference Type | active | 2025-01 | ||||
ca.on.health.idms | R5 | ValueSet/VALUESET-DOCUMENT-REFERENCE-LETTER-TYPES | DocumentReference Letter Types | active | 2025-01 | ||||
ca.on.health.idms | R5 | ValueSet/9ce0265f-05f2-4ca4-88d9-4f13ae2a67a9 | Document Reference Types | active | 2025-01 | ||||
ca.on.health.idms | R5 | ValueSet/IDMS-VALUESET-DRUG-CHARACTERISTIC | Drug Characteristics | active | 2024-01 | ||||
ca.on.health.idms | R5 | ValueSet/IDMS-VALUESET-DRUG-REVIEW-PATHWAY | Drug Review Pathways | active | 2027-01 | ||||
hl7.fhir.us.resp-net | R4 | ValueSet/resp-net-labtest-flu-codes | resp-net-labtest-flu-codes | draft | 2025-08 | us | hl7 | ||
hl7.fhir.us.resp-net | R4 | ValueSet/resp-net-labtest-flu-rsv-covid-codes | resp-net-labtest-flu-rsv-covid-codes | draft | 2025-08 | us | hl7 | ||
ca.on.health.idms | R5 | ValueSet/IDMS-ValueSet-FUNDING-PROGRAM | Funding Program | active | 2025-07 | ||||
ch.fhir.ig.ch-ems | R4 | ValueSet/IVR-VS-gcs-augenoeffnung | IVR GCS Eye Opening | draft | 2025-08 | ch | hl7 | ||
ch.fhir.ig.ch-ems | R4 | ValueSet/IVR-VS-gcsMotoric | IVR GCS Motoric Response | draft | 2025-08 | ch | hl7 | ||
ch.fhir.ig.ch-ems | R4 | ValueSet/IVR-VS-gcsVerbal | IVR GCS Verbal Response | draft | 2025-08 | ch | hl7 | ||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.6047 | Message Structure (Syndromic Surveillance) | active | 2019-01 | us | |||
ca.on.health.idms | R5 | ValueSet/IDMS-VALUESET-INDIVIDUAL-REVIEW-EXPERTISE | Reviewer Expertise | active | 2025-01 | ||||
hl7.fhir.uv.lab-report | R4 | ValueSet/orderCodes-uv-lab | Laboratory Order | trial-use | 2 | oo | 2025-01 | uv | hl7 |
hl7.fhir.eu.laboratory | R4 | ValueSet/lab-orderCodes-eu-lab | Laboratory Order | trial-use | 2 | 2025-07 | eu | hl7 | |
ca.on.health.idms | R5 | ValueSet/IDMS-ValueSet-Letter-Types | Letter Types | active | 2025-01 | ||||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3244 | Medication Treatment (Flu) | active | 2009-01 | us | |||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.1073 | Microbiology Test Result Name | active | 2008-01 | us | |||
ch.fhir.ig.ch-ems | R4 | ValueSet/IVR-VS-NACA | IVR NACA | draft | 2025-08 | ch | hl7 | ||
ca.on.health.idms | R5 | ValueSet/IDMS-VALUESET-NAME-PREFIX | Name Prefixes | active | 2025-01 | ||||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.1107 | Notification Section Header | active | 2015-01 | us | |||
ca.on.health.idms | R5 | ValueSet/ORGANIZATION-TYPE-ALL | Organization Types - All | active | 2025-01 | ||||
ca.on.health.idms | R5 | ValueSet/b6968639-cb27-4258-aad4-e4580577686d | Organization Types - Subset | active | 2025-01 | ||||
ca.on.health.idms | R5 | ValueSet/VALUESET-PACKAGE-TYPE | Package Types | active | 2025-01 | ||||
ca.on.health.idms | R5 | ValueSet/IDMS-VALUESET-PRODUCT-IDENTIFIER-TYPE | Product Identifier Types | active | 2025-01 | ||||
ca.on.health.idms | R5 | ValueSet/IDMS-Product-Types | Product Types | active | 2025-01 | ||||
ca.on.health.idms | R5 | ValueSet/9350b300-3e5f-4315-bb2a-4aa999748900 | Questionaires | active | 2029-08 | ||||
ca.on.health.idms | R5 | ValueSet/VALUESET-ROUTE-OF-ADMINISTRATION | Route of Administration | active | 2025-01 | ||||
hl7.fhir.us.resp-net | R4 | ValueSet/resp-net-labtest-rsv-codes | resp-net-labtest-rsv-codes | draft | 2025-08 | us | hl7 | ||
hl7.fhir.uv.radiation-dose-summary | R4 | ValueSet/radiopharmaceutical-rds-vs | Radiopharmaceuticals Value Set | trial-use | 2 | ii | 2025-05 | uv | hl7 |
ca.on.health.idms | R5 | ValueSet/IDMS-VALUESET-REQUEST-CONTACT-TYPE | Request Contact Type | active | 2025-01 | ||||
ca.on.health.idms | R5 | ValueSet/02420dfd-2388-4dea-b14a-1420c1e8a949-ACTIVE | Request Types (Active Only) | active | 2025-01 | ||||
ca.on.health.idms | R5 | ValueSet/02420dfd-2388-4dea-b14a-1420c1e8a949 | Request Types | active | 2025-01 | ||||
ca.on.health.idms | R5 | ValueSet/IDMS-VALUESET-CONTACT-TYPE | Reviewer Contact Type | active | 2025-01 | ||||
ca.on.health.idms | R5 | ValueSet/IDMS-VALUESET-SUBMISSION-NOTE-TYPE | Submission Note Type | active | 2024-01 | ||||
ca.on.health.idms | R5 | ValueSet/IDMS-VALUESET-PRICING-TYPES-ACTIVE | Pricing Types (Active Only) | active | 2025-01 | ||||
ca.on.health.idms | R5 | ValueSet/IDMS-VALUESET-PRICING-TYPES | Pricing Types | active | 2025-01 | ||||
ca.on.health.idms | R5 | ValueSet/IDMS-VALUESET-PRICING-TYPES-BIO | Pricing Types - Biosimilar Product | active | 2025-05 | ||||
ca.on.health.idms | R5 | ValueSet/IDMS-VALUESET-PRICING-TYPES-CGM | Pricing Types - Continuous Glucose Monitoring (CGM) | active | 2025-05 | ||||
ca.on.health.idms | R5 | ValueSet/IDMS-VALUESET-PRICING-TYPES-DIABETIC | Pricing Types - Diabetic Testing Agent (DTA) | active | 2025-05 | ||||
ca.on.health.idms | R5 | ValueSet/IDMS-VALUESET-PRICING-TYPES-MSDP | Pricing Types - Multiple Source Drug Product | active | 2025-05 | ||||
ca.on.health.idms | R5 | ValueSet/IDMS-VALUESET-PRICING-TYPES-NUTRITION | Pricing Types - Nutritional Product | active | 2025-05 | ||||
ca.on.health.idms | R5 | ValueSet/IDMS-VALUESET-PRICING-TYPES-SSP | Pricing Types - Single Source | active | 2025-05 | ||||
ca.on.health.idms | R5 | ValueSet/IDMS-VALUESET-PRICING-TYPES-VHC | Pricing Types - Valved Holding Chamber (VHC) | active | 2025-05 | ||||
ca.on.health.idms | R5 | ValueSet/0447bffa-01fa-4405-828a-96192e74a5d8 | Submission Types | active | 2025-01 | ||||
ca.on.health.idms | R5 | ValueSet/IDMS-VALUESET-OTHER-CHALLENGES | Submission Types - Challenges | active | 2024-01 | ||||
ca.on.health.idms | R5 | ValueSet/IDMS-VALUESET-OTHER-MANUFACTURER-INQUIRIES | Submission Types - Manufacturer Inquiries | active | 2025-01 | ||||
ca.on.health.idms | R5 | ValueSet/IDMS-VALUESET-OTHER-REDESIGNATION | Submission Types - Re-Designation of Benefits | active | 2025-01 | ||||
ca.on.health.idms | R5 | ValueSet/IDMS-VALUESET-SP-PRODUCT-SPECIAL-PROJECTS | Submission Types - Special Projects (Active Only) | active | 2025-01 | ||||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.6048 | Event Type (Syndromic Surveillance) | active | 2012-01 | us | |||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.6049 | Message Type (Syndromic Surveillance) | active | 2019-01 | us | |||
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.6050 | Universal ID Type (Syndromic Surveillance) | active | 2012-01 | us | |||
hl7.eu.fhir.idea4rc | R4 | ValueSet/drugsAtc-eu-i4rc | Antineoplastic and immunostimulating agents | draft | 2025-07 | eu | hl7 | ||
hl7.eu.fhir.pcsp | R4 | ValueSet/drugsAtc-eu-pcsp | Antineoplastic and immunostimulating agents | draft | 2025-08 | eu | hl7 | ||
ca.on.health.idms | R5 | ValueSet/IDMS-VALUESET-AUDIT-ENTITY-TYPE-ACTIVE | Audit Entity Type (Active Only) | active | 2025-01 | ||||
ca.on.health.idms | R5 | ValueSet/064df573-b528-420c-8935-5b70fd731511-ACTIVE | Authorization Roles (Active Only) | active | 2025-01 | ||||
ca.on.health.idms | R5 | ValueSet/IDMS-VALUESET-CROSS-REFERENCE-TYPE-ACTIVE | Cross Reference Type (Active Only) | active | 2025-01 | ||||
ca.on.health.idms | R5 | ValueSet/VALUESET-DOCUMENT-REFERENCE-LETTER-TYPES-ACTIVE | DocumentReference Letter Types (Active Only) | active | 2025-01 | ||||
ca.on.health.idms | R5 | ValueSet/9ce0265f-05f2-4ca4-88d9-4f13ae2a67a9-ACTIVE | Document Reference Types (Active Only) | active | 2025-01 | ||||
ca.on.health.idms | R5 | ValueSet/IDMS-VALUESET-DRUG-CHARACTERISTIC-ACTIVE | Drug Characteristics (Active Only) | active | 2024-01 | ||||
ca.on.health.idms | R5 | ValueSet/IDMS-VALUESET-DRUG-REVIEW-PATHWAY-ACTIVE | Drug Review Pathways (Active Only) | active | 2027-01 |